Europe — EMA

Oxaliplatin Fresenius Kabi Ltd

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Fresenius Kabi Ltd, is a platinum compound presented as a injection for intravenous use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatin Fresenius Kabi Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Oxaliplatin Fresenius Kabi Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a chemotherapy agent that acts on the DNA replication pathway. - Colorectal cancer: Improves the overall treatment outcome in patients receiving combined F‑ C F regimens. - Gastric govern go ... - ... ... ... ... … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →